Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Unleashing NK cell signaling to improve cancer immunotherapy].
Bernard PL, Laletin V, Pastor S, Nunès JA, Guittard G. Bernard PL, et al. Among authors: guittard g. Med Sci (Paris). 2020 Oct;36 Hors série n° 1:50-55. doi: 10.1051/medsci/2020195. Epub 2020 Oct 14. Med Sci (Paris). 2020. PMID: 33052095 Free article. Review. French. No abstract available.
Dok-4 is a novel negative regulator of T cell activation.
Gérard A, Ghiotto M, Fos C, Guittard G, Compagno D, Galy A, Lemay S, Olive D, Nunès JA. Gérard A, et al. Among authors: guittard g. J Immunol. 2009 Jun 15;182(12):7681-9. doi: 10.4049/jimmunol.0802203. J Immunol. 2009. PMID: 19494292 Free PMC article.
An Emerging Role for PI5P in T Cell Biology.
Nunès JA, Guittard G. Nunès JA, et al. Among authors: guittard g. Front Immunol. 2013 Apr 2;4:80. doi: 10.3389/fimmu.2013.00080. eCollection 2013. Front Immunol. 2013. PMID: 23565114 Free PMC article.
Vitamin D Controls Tumor Growth and CD8+ T Cell Infiltration in Breast Cancer.
Karkeni E, Morin SO, Bou Tayeh B, Goubard A, Josselin E, Castellano R, Fauriat C, Guittard G, Olive D, Nunès JA. Karkeni E, et al. Among authors: guittard g. Front Immunol. 2019 Jun 6;10:1307. doi: 10.3389/fimmu.2019.01307. eCollection 2019. Front Immunol. 2019. PMID: 31244851 Free PMC article.
NK Cell Priming From Endogenous Homeostatic Signals Is Modulated by CIS.
Delconte RB, Guittard G, Goh W, Hediyeh-Zadeh S, Hennessy RJ, Rautela J, Davis MJ, Souza-Fonseca-Guimaraes F, Nunès JA, Huntington ND. Delconte RB, et al. Among authors: guittard g. Front Immunol. 2020 Jan 31;11:75. doi: 10.3389/fimmu.2020.00075. eCollection 2020. Front Immunol. 2020. PMID: 32082327 Free PMC article.
TET2 regulates immune tolerance in chronically activated mast cells.
Rigo R, Chelbi R, Agopian J, Letard S, Griffon A, Ghamlouch H, Vernerey J, Ladopoulos V, Voisset E, De Sepulveda P, Guittard G, Nunès JA, Bidaut G, Göttgens B, Weber M, Bernard OA, Dubreuil P, Soucie E. Rigo R, et al. Among authors: guittard g. JCI Insight. 2022 Apr 8;7(7):e154191. doi: 10.1172/jci.insight.154191. JCI Insight. 2022. PMID: 35393954 Free PMC article.
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.
Bernard PL, Delconte R, Pastor S, Laletin V, Costa Da Silva C, Goubard A, Josselin E, Castellano R, Krug A, Vernerey J, Devillier R, Olive D, Verhoeyen E, Vivier E, Huntington ND, Nunes J, Guittard G. Bernard PL, et al. Among authors: guittard g. J Immunother Cancer. 2022 May;10(5):e004244. doi: 10.1136/jitc-2021-004244. J Immunother Cancer. 2022. PMID: 35589278 Free PMC article.
29 results